Ann: Merger Update, page-213

First 213 Last

Share
Profile

Follow
Novice2012

591 Posts.

35

20/09/18

07:29

Post #: 35714321
Share

Originally posted by kropka ↑

It is nothing new for Australian investors to hold shares in foreign exchange and I have no problem with it.

My issue is how all was slowly orchestrated. Firstly they forced overseas investors to sell their shares either on ASX or JSE and I think that all those holdings are now hidden thru number of nominees accounts so no one knows who holds large stakes.

Now, they created panic among Aussie shareholders to scoop more in order to prevent any resolution go thru honest voting.

With 1 share 1 vote scenario it is just formality for yes/no vote count.

My fear is that the next step in 2019 will be a low ball figure on SGX from our Chinese top holders and get only peanuts what BH is worth.

BOD holding millions of shares? don't worry about them losing on it. There are always performance cash bonuses to make up for losses.

Next will be COW. First they will use Aussie investors to contribute to CR's before AMAL will present TO bid.
With 15% holding (via TAW), BOD holdings and the rest of shares they collected from overseas and current frustrated investors , you can be sure they will have 75% to accept another low ball offer.

There is no doubt BH will be a success listed by 2020 in Hong Kong board under Burwill name.

No wonder they gave us a loan with no interest attached. Well planned and well executed.

Australian mine, AMAL and TAW office based in Australia and trading under foreign jurisdiction.

Perhaps latest announcements should have bold letters - Attention all MUSHROOMS !!!! because now I feel like one - kept in dark and fed with BS.

Expand

Is it fair to say COW will be a dud after all this drama cause by managment?

TAW Price at posting: 25.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 91 more messages in this thread...

First 213 Last

Add TAW (ASX) to my watchlist

Ann: Merger Update, page-213

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News